Global Drug Device Combination Market to Hit $115B by 2019

The global drug device combination products market is expected to reach $115.1 billion by 2019, growing at a compound annual growth rate of 7.9 percent, according to a news release.

Advertisement

In 2012, the market was valued at $66 billion.

Drug device combination products combine a drug and medical device to be produced as a single product, such as infusion pumps, inhalers, coronary stents and intraocular implants.

The growing elderly population is contributing to the rise in demand for drug device combination products, according to the report.

More Articles on Medical Device Markets:

Infection Control Market Expected to Reach $14B by 2017
Global Medical Device Packaging Market to Reach $26B by 2017

Medical Bionic Implant Market to Hit $18B by 2017

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.